Vireo Growth (VREOF) Operating Margin Growth (3y) (2023 - 2026)
Vireo Growth (VREOF) Operating Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.41 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.50 Bn | 29.83 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Vireo Growth | 491.44 Mn | 349.14 Mn | 95.30 Mn | 215.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 654.00 |
| Dec 31, 2025 | -542.00 |
| Sep 30, 2025 | 189.00 |
| Jun 30, 2025 | -566.00 |
| Mar 31, 2025 | 5,779.00 |
| Dec 31, 2024 | 5,711.00 |
| Sep 30, 2024 | 4,620.00 |
| Jun 30, 2024 | 4,590.00 |
| Mar 31, 2024 | 5,649.00 |
| Dec 31, 2023 | 4,024.00 |
| Sep 30, 2023 | 4,198.00 |
| Jun 30, 2023 | 9,350.00 |
| Mar 31, 2023 | 5,550.00 |